SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adorbs Inc. – ‘10-12G/A’ on 11/18/20 – ‘EX-99.25’

On:  Wednesday, 11/18/20, at 2:34pm ET   ·   Accession #:  1213900-20-37931   ·   File #:  0-56213

Previous ‘10-12G’:  ‘10-12G’ on 10/7/20   ·   Next:  ‘10-12G/A’ on 12/14/20   ·   Latest:  ‘10-12G/A’ on 12/22/20   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/20  Adorbs Inc.                       10-12G/A               6:838K                                   EdgarAgents LLC/FA

Amendment to Registration Statement   —   Form 10   —   Sect. 12(g) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12G/A    Amendment No. 1 to Form 10-12G                      HTML    333K 
 2: EX-99.22    Demand Promissory Note Payable to Activist          HTML     11K 
                Investing LLC                                                    
 3: EX-99.23    Demand Promissory Note Payable to Rebecca Lazar     HTML     11K 
 4: EX-99.24    Consent of Independent Auditor                      HTML      5K 
 5: EX-99.25    Consent of Prior Independent Auditor                HTML      6K 
 6: EX-99.26    Michael Gillespie & Associates, Pllc No             HTML      6K 
                Disagreement Letter to the Securities and Exchange               
                Commission                                                       


‘EX-99.25’   —   Consent of Prior Independent Auditor


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 25

 

MICHAEL GILLESPIE & ASSOCIATES, PLLC

CERTIFIED PUBLIC ACCOUNTANTS

10544 ALTON AVE NE

SEATTLE, WA 98125

206.353.5736

 

Consent of Independent Registered Public Accounting Firm

 

To the Board of Directors

Adorbs Inc.

 

We consent to the use of our report dated April 10, 2019 with respect to the financial statements of Adorbs Inc. as of December 31, 2018 and the related statements of operations, shareholders’ deficit and cash flows for the year ended December 31, 2018 and solely to information presented to which falls under the year ended December 31, 2018. We also consent to the reference to our firm under the caption “Experts” in the Registration Statement.

 

Michael Gillespie & Associates, PLLC

Seattle, Washington

November 18, 2020

 

/S/ Michael Gillespie & Associates, PLLC


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-12G/A’ Filing    Date    Other Filings
Filed on:11/18/20CORRESP
4/10/1910-K
12/31/1810-K,  10-K/A,  NT 10-K
 List all Filings 


14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/20/23  Adorbs Inc.                       10-Q        9/30/23   41:2.4M                                   Empire Filings/FA
 9/27/23  Soul Biotechnology Corp.          10-Q        6/30/23   41:2.4M                                   Empire Filings/FA
 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA
10/21/22  Soul Biotechnology Corp.          10-Q        9/30/22   38:2.4M                                   Empire Filings/FA
 8/01/22  Soul Biotechnology Corp.          10-Q        6/30/22   38:2.1M                                   Empire Filings/FA
 5/10/22  Soul Biotechnology Corp.          10-Q        3/31/22   38:1.8M                                   Empire Filings/FA
 2/08/22  Soul Biotechnology Corp.          10-K       12/31/21   29:1.4M                                   Empire Filings/FA
12/09/21  Soul Biotechnology Corp.          10-K/A     12/31/20   28:1M                                     Empire Filings/FA
10/13/21  Soul Biotechnology Corp.          10-Q        9/30/21   29:1.3M                                   Empire Filings/FA
 7/23/21  Soul Biotechnology Corp.          10-Q        6/30/21   29:1.3M                                   Empire Filings/FA
 5/03/21  Soul Biotechnology Corp.          10-Q        3/31/21   28:926K                                   EdgarAgents LLC/FA
 2/10/21  Soul Biotechnology Corp.          10-K       12/31/20   28:1.1M                                   EdgarAgents LLC/FA
12/22/20  Soul Biotechnology Corp.          10-12G/A               4:704K                                   EdgarAgents LLC/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/19/18  Soul Biotechnology Corp.          S-1                    6:1M                                     S2 Filings LLC/FA
Top
Filing Submission 0001213900-20-037931   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 3:00:56.2pm ET